SC
RXST icon

Sessa Capital’s RxSight RXST Stock Holding History

Sessa Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-135,779
Closed -$1.63M – 38
2022
Q3 		$1.63M Sell
135,779
-28,503
-17% -$391K 0.12% 29
2022
Q2 		$2.31M Hold
164,282
– – 0.13% 30
2022
Q1 		$2.03M Hold
164,282
– – 0.1% 42
2021
Q4 		$1.85M Buy
+164,282
New +$1.97M 0.09% 39

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sessa Capital's RXST Position: Q4 2022 in Review

Sessa Capital sold out of RxSight (RXST) in Q4 2022, closing a stake of 135,779 shares — an estimated $1.63M sold.

Sessa Capital first reported a position in RXST in Q4 2021 and held it in 4 quarters. The position peaked at $2.31M in Q2 2022. 58 funds tracked by Wall St. Rank hold RXST as of Q4 2022.

  • Sessa Capital reported no remaining RxSight position as of Q4 2022 after selling out during the quarter.
  • Sessa Capital sold 135,779 RxSight shares in Q4 2022, an estimated $1.63M.
  • Sessa Capital first reported a position in RxSight in Q4 2021 and held it in 4 quarters.
  • Sessa Capital's RxSight position peaked at $2.31M in Q2 2022.
  • 58 funds tracked by Wall St. Rank held RxSight as of Q4 2022.

Based on Sessa Capital's 13F filing for Q4 2022, filed 14 Feb 2023.